BD² Launches Historic Multimodal Bipolar Disorder Dataset Combining Clinical, Biological, and Real-World Wearable Sensor Data

BD² launches a historic psychiatric dataset combining MRI, blood markers, and wearable data to accelerate personalized care for those with bipolar disorder.

By: AXL Media

Published: Mar 31, 2026, 5:47 AM EDT

Source: Information for this report was sourced from BD²: Breakthrough Discoveries for thriving with Bipolar Disorder

A New Infrastructure for Fragmented Psychiatric Research

For decades, the study of bipolar disorder has been hindered by a lack of shared standards and deeply fragmented data collection, leaving many biological mechanisms of the condition misunderstood. The release of the BD² Integrated Network Longitudinal Cohort Study (LCS) dataset marks a fundamental shift in this ecosystem by providing a unified foundation for research. According to Cara Altimus, PhD, CEO of BD², the organization was created to transform a severely underfunded field into one capable of producing life-changing clinical breakthroughs. By establishing shared data protocols, the network allows researchers to move beyond isolated observations toward a comprehensive understanding of how the disorder evolves over time.

Integrating Multimodal Data for Deep Phenotyping

What distinguishes this dataset from previous psychiatric studies is its massive scope and the diversity of its data modalities. The initial release includes information from 615 participants across six sites, integrating clinician assessments with high-resolution MRI neuroimaging and blood-based bioassays. Furthermore, the inclusion of continuous wearable sensor data from Fitbit devices allows researchers to track real-world behavioral patterns, such as sleep-wake cycles and circadian rhythms, which are often disrupted in individuals with bipolar disorder. This "deep phenotyping" at scale is essential for identifying the subtle measurable indicators of disease progression that were previously invisible in smaller, single-modality studies.

Accelerating Discovery Through the Learning Health Network

The BD² initiative is uniquely embedded within a Learning Health Network (LHN), a structure designed to shorten the time it takes for a scientific discovery to reach a patient's bedside. This model ensures that insights gained from the longitudinal study are rapidly shared with clinicians, while real-world observations from active clinics help shape the next generation of research questions. Ekemini A.U. Riley, PhD, noted that this paradigm shift is necessary to prevent discoveries from stalling in the lab. By uniting clinical practice with the lived experiences of those with bipolar disorder, the network facilitates a continuous cycle of improvement in patient care and treatment efficacy.